Clinical Trials Browser

Phase 2/3 × Arthritis, Juvenile × Clear all

NCT01385826 2025-09-08

ADJUVITE

Phase 2/3 Completed

Arthritis, Juvenile, Uveitis

NCT03780959 2019-08-02

Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)

Phase 2/3 Completed

69 enrolled 11 charts

Arthritis, Juvenile